As of 2025-10-29, the Relative Valuation of Passage Bio Inc (PASG) is (303.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.66 USD, the upside of Passage Bio Inc based on Relative Valuation is -4056.2%.
The range of the Relative Valuation is (288.92) - (318.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 17.8x | 17.0x |
| Forward P/E multiples | 16.0x - 17.8x | 16.9x |
| Fair Price | (288.92) - (318.24) | (303.05) |
| Upside | -3871.8% - -4254.6% | -4056.2% |
| Date | P/E |
| 2025-10-16 | -0.45 |
| 2025-10-15 | -0.48 |
| 2025-10-14 | -0.48 |
| 2025-10-13 | -0.49 |
| 2025-10-10 | -0.47 |
| 2025-10-09 | -0.49 |
| 2025-10-08 | -0.46 |
| 2025-10-07 | -0.44 |
| 2025-10-06 | -0.44 |
| 2025-10-03 | -0.44 |
| 2025-10-02 | -0.45 |
| 2025-10-01 | -0.45 |
| 2025-09-30 | -0.45 |
| 2025-09-29 | -0.46 |
| 2025-09-26 | -0.45 |
| 2025-09-25 | -0.43 |
| 2025-09-24 | -0.43 |
| 2025-09-23 | -0.42 |
| 2025-09-22 | -0.42 |
| 2025-09-19 | -0.40 |
| 2025-09-18 | -0.42 |
| 2025-09-17 | -0.39 |
| 2025-09-16 | -0.41 |
| 2025-09-15 | -0.39 |
| 2025-09-12 | -0.39 |
| 2025-09-11 | -0.39 |
| 2025-09-10 | -0.39 |
| 2025-09-09 | -0.39 |
| 2025-09-08 | -0.39 |
| 2025-09-05 | -0.40 |
| 2025-09-04 | -0.39 |
| 2025-09-03 | -0.40 |
| 2025-09-02 | -0.40 |
| 2025-08-29 | -0.40 |
| 2025-08-28 | -0.39 |
| 2025-08-27 | -0.39 |
| 2025-08-26 | -0.39 |
| 2025-08-25 | -0.42 |
| 2025-08-22 | -0.42 |
| 2025-08-21 | -0.41 |
| 2025-08-20 | -0.43 |
| 2025-08-19 | -0.39 |
| 2025-08-18 | -0.40 |
| 2025-08-15 | -0.39 |
| 2025-08-14 | -0.42 |
| 2025-08-13 | -0.36 |
| 2025-08-12 | -0.31 |
| 2025-08-11 | -0.33 |
| 2025-08-08 | -0.35 |
| 2025-08-07 | -0.31 |